COVID-19: Clinical trial of “Avigan” in Egypt: starting April 17, administered to 50 people
COVID-19:
The clinical trial of “Avigan” against the new coronavirus has started in Egypt.
Local Egyptian Newspaper: Egypt Today
The clinical trial using the new influenza drug “Avigan” was started on the 17th and it was announced that it has already been administered to 50 people.
Patients are admitted to multiple facilities.
Egyptian Government:
The government wants to determine if “Avigan” is effective against the new coronavirus by looking at the future progress.
So far, 2,844 cases of infection and 205 deaths have been announced in Egypt.
https://news.tbs.co.jp/sp/newseye/tbs_newseye3958846.html
Egypt to test Japanese anti-viral drug Avigan in clinical trials
CAIRO – 12 April 2020: Egypt is getting ready to conduct clinical trials on samples of the Japanese anti-viral drug Aviral as a treatment for COVID-19,
Advisor to the Minister of Higher Education for International Relations and Agreements for Scientific Research Affairs, Dr. Mohamed Al-Shennawy, said on Sunday.
On Friday, Minister of Higher Education and Scientific Research Khaled Abdel Ghaffar
said the ministry has managed to communicate with the Japanese manufacturer of the antiviral drug Avigan to treat patients with coronavirus (COVID-19).
The drug, developed by a group firm of Fujifilm Holdings Corp., has been stored in Japan as a treatment for influenza.
Reports in China showed that the drug has been effective in treating COVID-19, the respiratory disease caused by the virus.
Fujifilm Holdings Corp said on Thursday it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States, according to the NY Times.
The minister further added that Egypt is joining scientific research with Japan in an attempt to reach a medicine for the novel pandemic.
On March 31, Fujifilm announced the start of a phase III clinical trial of Avigan for COVID-19 patients in Japan.
Egypt Today
https://www.egypttoday.com/Article/1/84595/Egypt-to-test-Japanese-anti-viral-drug-Avigan-in-clinical